Published in Ann Oncol on March 01, 1999
The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg (2004) 1.25
Physician, patient, and contextual factors affecting treatment decisions in older adults with cancer and models of decision making: a literature review. Oncol Nurs Forum (2012) 0.96
Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer (2007) 0.82
Primary non-hodgkin lymphoma of the stomach: clinicopathological characteristics and prognostic factors in Iranian patients. Iran J Cancer Prev (2014) 0.81
Diagnosis, treatment decisions, and follow up in primary gastric lymphoma. Gut (2002) 0.78
Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy? J Hematol Oncol (2010) 0.78
The clinical characteristics and treatment results of ocular adnexal lymphoma. Korean J Ophthalmol (2006) 0.78
Patient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma. Cancer Treat Commun (2014) 0.75
Ocular surface tumors. Oman J Ophthalmol (2009) 0.75
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology (1996) 3.54
Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma. Cancer (2000) 2.82
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol (2000) 2.71
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol (2001) 2.71
Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum (1995) 2.15
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut (2011) 1.96
Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut (1997) 1.88
Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol (1996) 1.84
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer. Ann Oncol (2003) 1.65
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer (1998) 1.49
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]. Ned Tijdschr Geneeskd (2005) 1.48
Cardiac tamponade from misplaced central venous line in pericardiophrenic vein. Arch Intern Med (1988) 1.48
Smoking and older age associated with mumps in an outbreak in a group of highly-vaccinated individuals attending a youth club party, the Netherlands, 2012. Euro Surveill (2014) 1.46
Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer (2001) 1.45
Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill (2010) 1.43
Indices from flow-volume curves in relation to cephalometric, ENT- and sleep-O2 saturation variables in snorers with and without obstructive sleep-apnoea. Eur Respir J (1995) 1.39
Expandable stents compared to conventional plastic endoprostheses in malignant oesophageal obstruction, especially in cardiac cancer and fistulas: the experience of the Netherlands Cancer Institute. Eur J Gastroenterol Hepatol (1998) 1.39
The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer (1996) 1.35
Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol (2001) 1.33
Clinical and endoscopic features of melanoma metastases in the upper GI tract. Gastrointest Endosc (1999) 1.32
Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology (1997) 1.30
Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma. Histopathology (2005) 1.27
A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer (2009) 1.22
Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Br J Surg (2010) 1.21
Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors. J Clin Oncol (1996) 1.11
Treatment of malignancy arising in pilonidal disease. Ann Surg Oncol (2001) 1.11
Role of Helicobacter pylori eradication in high-grade MALT lymphoma. Lancet (1995) 1.09
Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut (1994) 1.09
Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma. Immunology (1998) 1.06
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer (1995) 1.04
Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl Med Commun (2002) 1.04
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol (1989) 1.01
Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting. Ann Oncol (1994) 1.00
Probabilities for a probabilistic network: a case study in oesophageal cancer. Artif Intell Med (2002) 0.98
Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours. Eur J Cancer (1996) 0.97
Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer (2008) 0.96
Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol (2005) 0.96
Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol (1988) 0.96
Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl (2004) 0.95
The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol (1994) 0.95
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol (2001) 0.92
Non-allelic heterogeneity of familial adenomatous polyposis. Am J Med Genet (1993) 0.92
EAP in advanced gastric cancer. J Clin Oncol (1990) 0.91
A tumour with a neuroendocrine and papillary serous component: two or a pair? J Clin Pathol (2002) 0.91
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer (2007) 0.91
Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin. Anal Bioanal Chem (2008) 0.90
High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer (1996) 0.89
Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. Hepatogastroenterology (1983) 0.89
Pouchitis (pouch ileitis). Neth J Med (1989) 0.89
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer Chemother Pharmacol (2015) 0.88
Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice. Ann Oncol (2000) 0.88
The role of I-131-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med (1987) 0.88
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut (2006) 0.88
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Br J Cancer (2004) 0.87
Assessing the introduction of universal rotavirus vaccination in the Netherlands. Vaccine (2008) 0.87
Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma. Neth J Med (2006) 0.85
Computer-based decision support in the management of primary gastric non-Hodgkin lymphoma. Methods Inf Med (1998) 0.85
Histological grading with clinical relevance in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Recent Results Cancer Res (2000) 0.84
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol (2009) 0.84
Pulmonary hypertension complicating portal hypertension. A case report with suggestions for a different therapeutic approach. Eur Heart J (1987) 0.83
Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions. Gastrointest Endosc (1995) 0.83
Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone. Cancer Chemother Pharmacol (1992) 0.83
Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody. J Histochem Cytochem (2000) 0.82
Serum IgM in primary biliary cirrhosis. Clin Chim Acta (1980) 0.82
Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance. Nucl Med Commun (1995) 0.82
The antibacterial activity of benzylpenicillin against Staphylococcus aureus ingested by granulocytes. J Antimicrob Chemother (1990) 0.81
Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? Eur J Surg Oncol (2013) 0.81
Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis. Liver (1983) 0.81
An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival. Ann Oncol (2011) 0.81
Pleuropulmonary fibrosis associated with chronic and excessive intake of ergotamine. Thorax (1983) 0.81
Quality-of-care indicators for oesophageal cancer surgery: A review. Eur J Surg Oncol (2010) 0.81
HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison. J Cancer Res Clin Oncol (2014) 0.80
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour. Eur J Cancer (1992) 0.80
On attitudes about colorectal cancer screening among gastrointestinal specialists and general practitioners in the Netherlands. World J Gastroenterol (2006) 0.80
Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination. Eur J Gastroenterol Hepatol (1999) 0.80
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study. Eur J Cancer (1996) 0.80
A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer. Colorectal Dis (2014) 0.78
CagA+ H. pylori strains and gastric lymphoma. Gastroenterology (1997) 0.78
Carcinoid heart disease: an update. Scand J Gastroenterol Suppl (2002) 0.78
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours. Br J Cancer (2011) 0.78
[Periodic colonoscopic examinations of persons with a positive family history for colorectal cancer. Work Group 'Hereditary non-polyposis- colon-rectum cancers']. Ned Tijdschr Geneeskd (1999) 0.78
Surgical intervention for complications caused by late radiation damage of the small bowel: a retrospective analysis. Eur J Surg Oncol (1993) 0.77
Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide. Ann Oncol (1994) 0.77
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours. Endocr Relat Cancer (2004) 0.77
Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids. J Endocrinol Invest (2010) 0.77
Risk factors for the development of oesophageal cancer as a second primary tumour. Eur J Cancer (1995) 0.77
High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients. J Pharm Biomed Anal (1994) 0.77
Prognostication and prediction using gene expression profiling in oesophageal cancer. Eur J Surg Oncol (2012) 0.77